WallStreetZenWallStreetZen

NYSEMKT: CCEL
Cryo Cell International Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cryo Cell International earnings were $128.7k for the trailing 12 months ending Feb 28, 2025, with N/A growth year over year. The latest CCEL earnings report on Feb 28, 2025 announced Q1 2025 earnings of $282.9k, down 115.2% from last quarter. For the last reported fiscal year 2024 ending Nov 30, 2024, CCEL reported annual earnings of $402.1k, with -104.2% growth. The next CCEL earnings date is Jul 14, 2025.

CCEL past earnings growth

How has CCEL's earnings growth performed historically?

Company
N/A
Industry
12.71%
Market
33.9%
CCEL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CCEL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

CCEL earnings history

Current Revenue
$32.1M
Current Earnings
$128.7k
Current Profit Margin
0.4%
CCEL's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CCEL Return on Equity

Current Company
-1.1%
Current Industry
-68%
Current Market
31.3%
CCEL's Return on Equity (-1.1%)... subscribe to Premium to read more.
High Return on Equity Performance

CCEL undefined

Current Company
0.2%
Current Industry
6.8%
CCEL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CCEL announces earnings.

CCEL undefined

Current Company
10.89%
Current Industry
14.3%
CCEL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CCEL vs Medical Care Facility Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CCEL$5.85M$128.71k-50.60%$0.01
PIII-$22.03M-$137.63MN/A-$44.78
MODV$1.20M-$229.36MN/A-$16.10
CCM$1.53M-$42.17MN/A-$9.64
BMGLN/AN/AN/AN/A
View Top Medical Care Facility Stocks

CCEL earnings dates

Next earnings date
Jul 14, 2025

Cryo Cell International Earnings Reports & History FAQ

What were Cryo Cell International's earnings last quarter?

On CCEL's earnings call on Invalid Date, Cryo Cell International (NYSEMKT: CCEL) reported Q1 2025 earnings per share (EPS) of $0.03, up 57.14% year over year. Total CCEL earnings for the quarter were $282.86 thousand. In the same quarter last year, Cryo Cell International's earnings per share (EPS) was $0.07.

If you're new to stock investing, here's how to buy Cryo Cell International stock.

When does Cryo Cell International report earnings?

The next CCEL earnings date is Invalid Date. Add CCEL to your watchlist to be reminded of Cryo Cell International's next earnings date.

Is Cryo Cell International profitable or losing money?

As of the last Cryo Cell International earnings report, Cryo Cell International is currently profitable. Cryo Cell International's net profit (also called net income) for the twelve months ending Feb 28, 2025 was $128.71 thousand, a 101.32% decrease year over year.

What was CCEL's earnings growth in the past year?

As of Cryo Cell International's earnings date in Invalid Date, Cryo Cell International's earnings has grown year over year. CCEL earnings in the past year totalled $128.71 thousand.

What are Cryo Cell International's earnings expectations?

The current EPS estimate for Cryo Cell International's earnings report in Invalid Date is $0.03.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.